Breast cancer is a heterogeneous disease comprised of distinct molecular subtypes that can be generally characterized by the expression status of receptors for estrogen (ER), progesterone (PR), human epidermal growth factor receptor 2 (HER2) and more recently, androgen (AR). This evidence concerns the gene ERBB2 and breast cancer.